The role of RamA on the development of ciprofloxacin resistance in Salmonella enterica serovar Typhimurium

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Sun, Yawei ^a   Dai, Menghong ^a   Hao, Haihong ^a   Wang, Yulian ^a   Huang, Lingli ^a   Almofti, Yassir A ^a   Liu, Zhenli ^a   Yuan, Zonghui ^a  

^a HUAZHONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; CARRIER PROTEIN; DIPEPTIDE; MULTIDRUG RESISTANCE PROTEIN; NALIDIXIC ACID; PHENYLALANINE ARGININE BETA NAPHTHYLAMIDE; PHENYLALANINE ARGININE BETA-NAPHTHYLAMIDE; PROTON IONOPHORE; RAMA PROTEIN, SALMONELLA TYPHIMURIUM; TRANSACTIVATOR PROTEIN;

ACRAB GENE; AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM CULTURE; BACTERIUM MUTANT; CONTROLLED STUDY; FLUOROMETRY; GENE; GENE FUNCTION; GENE OVEREXPRESSION; KAN GENE; MINIMUM INHIBITORY CONCENTRATION; MTDK GENE; MULTIDRUG RESISTANCE; NONHUMAN; RAMA GENE; REAL TIME POLYMERASE CHAIN REACTION; RECOMBINANT PLASMID; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM; SEROTYPE; UPREGULATION; DOSE RESPONSE; DRUG EFFECT; ESCHERICHIA COLI; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MICROBIOLOGICAL EXAMINATION; MOLECULAR GENETICS; MUTATION; PHYSIOLOGY; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSPORT AT THE CELLULAR LEVEL;

SALMONELLA ENTERICA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM;

ANTI-INFECTIVE AGENTS; BACTERIAL PROTEINS; BIOLOGICAL TRANSPORT; CARBONYL CYANIDE M-CHLOROPHENYL HYDRAZONE; CIPROFLOXACIN; DIPEPTIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; GENE EXPRESSION REGULATION, BACTERIAL; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; MUTATION; NALIDIXIC ACID; PROMOTER REGIONS, GENETIC; PROTON IONOPHORES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SALMONELLA TYPHIMURIUM; TRANS-ACTIVATORS;

EID: 80051614619     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023471     Document Type: Article

References (50)

1. Voetsch AC, Van Gilder TJ, Angulo FJ, Farley MM, Shallow S, et al. (2004) Food Net estimate of the burden of illness caused by nontyphoidal Salmonella infections in the United States. Clin Infect Dis 38 (Supple 3): S127-134.
2. Levy SB, Marshall B, (2004) Antibacterial resistance worldwide: causes, challenges and responses. Nat Med 10: 122-129.
3. Cosgrove SE, (2006) The Relationship between Antimicrobial Resistance and Patient Outcomes: Mortality, Length of Hospital Stay, and Health Care Costs. Clin Infect Dis 42 (supple 2): S82-89.
4. Ruiz J, (2003) Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection. J Antimicrob Chemother 51: 1109-1117.
5. Giraud E, Baucheron S, Cloeckaert A, (2006) Resistance to fluoroquinolones in Salmonella: emerging mechanisms and resistance prevention strategies. Microbes Infect 8: 1937-1944.
6. Chen FJ, Lo HJ, (2003) Molecular mechanism of fluoroquinolone resistance. J Microbiol Immunol Infect 36: 1-9.
7. Katie LH, Robert HD, Threlfall EJ, (2005) Mechanisms of quinolone resistance in Escherichia coli and Salmonella: Recent developments. Int J Antimicrob Agents 25: 358-373.
8. Nishino K, Latifi T, Groisman EA, (2006) Virulence and drug resistance roles of multidrug efflux systems of Salmonella enterica serovar Typhimurium. Mol Microbiol 59: 126-141.
9. Giraud E, Cloeckaert A, Kerboeuf D, Chaslus-Dancla E, (2000) Evidence for Active Efflux as the Primary Mechanism of Resistance to Ciprofloxacin in Salmonella enterica Serovar Typhimurium. Antimicrob Agents Chemother 44: 1223-1228.
10. Escribano I, Rodríguez JC, Cebrian L, Royo G, (2004) The importance of active efflux systems in the quinolone resistance of clinical isolates of Salmonella spp. Int J Antimicrob Agents 24: 428-432.
11. Koutsolioutsou A, Martins EA, White DG, Levy SB, Demple B, (2001) A SoxRS-Constitutive Mutation Contributing to Antibiotic Resistance in a Clinical Isolate of Salmonella enterica (Serovar Typhimurium). Antimicrob Agents Chemother 45: 38-43.
12. Sulavik M, Dazer M, Miller PF, (1997) The Salmonella typhimurium mar Locus: Molecular and Genetic Analyses and Assessment of Its Role in Virulence. J Bacteriol 179: 1857-1866.
13. Oliver A, Valle′ M, Chaslus-Dancla E, Cloeckaert A, (2004) Role of an acrR mutation in multidrug resistance of in vitro-selected fluoroquinolone-resistant mutants of Salmonella enterica Serovar Typhimurium. FEMS Microbiol Lett 238: 267-272.
14. Straaten T, Janssen R, Mevius DJ, Dissel JP, (2004) Salmonella Gene rma (ramA) and Multiple-Drug-Resistant Salmonella enterica Serovar Typhimurium. Antimicrob Agents Chemother 48: 2292-2294.
15. Straaten T, Zulianello L, Diepen A, Granger DL, Janssen R, et al. (2004) Salmonella enterica Serovar Typhimurium RamA, Intracellular Oxidative Stress Response, and Bacterial Virulence. Infect Immun 72: 996-1003.
16. Nikaido E, Yamaguchi A, Nishino K, (2008) AcrAB Multidrug Efflux Pump Regulation in Salmonella enterica serovar Typhimurium by RamA in Response to Environmental Signals. J Biol Chem 283: 24245-24253.
17. Abouzeed YM, Baucheron S, Cloeckaert A, (2008) ramR Mutations Involved in Efflux-Mediated Multidrug Resistance in Salmonella enterica Serovar Typhimurium. Antimicrob Agents Chemother 52: 2428-2434.
18. Kehrenberg C, Cloeckaert A, Klein G, Schwarz S, (2009) Decreased fluoroquinolone susceptibility in mutants of Salmonella serovars other than Typhimurium: detection of novel mutations involved in modulated expression of RamA and SoxS. J Antimicrob Chemother 64: 1175-1180.
19. Dong YZ, Zhao XL, Domagala J, Drlica K, (1999) Effect of Fluoroquinolone Concentrationon Selection of Resistant Mutants of Mycobacterium bovis BCG and Staphylococcus aureus. Antimicrob Agents Chemother 43: 1756-1758.
20. Drlica K, Zhao XL, (2007) Mutant Selection Window Hypothesis Updated. Clin Infect Dis 44: 681-688.
21. Drlica K, (2003) The mutant selection window and antimicrobial resistance. J Antimicrob Chemother 52: 11-17.
22. Rodríguez JC, Cebrián López LM, Ruiz M, Jiménez I, Royo G, (2004) Mutant prevention concentration: comparison of fluoroquinolones and linezolid with Mycobacterium tuberculosis. J Antimicrob Chemother 53: 441-444.
23. Hansen GT, Metzler K, Drlica K, Blondeau JM, (2003) Mutant Prevention Concentration of Gemi floxacin for Clinical Isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother 47: 440-441.
24. Linde HJ, Lehn N, (2004) Mutant prevention concentration of nalidixic acid, ciprofloxacin, clinafloxacin, levofloxacin, norfloxacin, ofloxacin, sparfloxacin or trovafloxacin for Escherichia coli under different growth conditions. J Antimicrob Chemother 53: 252-257.
25. Hansen GT, Zhao XL, Drlica K, Blondeau JM, (2006) Mutant prevention concentration for cipro floxacin and levo floxacin with Pseudomonas aeruginosa. Int J Antimicrob Agents 27: 120-124.
26. Randall LP, Cooles SW, Piddock LJV, Woodward MJ, (2004) Mutant prevention concentrations of cipro floxacin and enro floxacin for Salmonella enterica. J Antimicrob Chemother 54: 688-691.
27. Kehrenberg C, Jong A, Friederichs S, Cloeckaert A, Schwarz S, (2007) Molecular mechanisms of decreased susceptibility to fluoroquinolones in avian Salmonella serovars and their mutants selected during the determination of mutant prevention concentrations. J Antimicrob Chemother 59: 886-892.
28. Ferrari R, Magnani M, Souza RB, Tognim MCB, Oliveira TCRM, (2011) Mutant Prevention Concentration (MPC) of Cipro floxacin against Salmonella enterica of Epidemic and Poultry Origin. Curr Microbiol 62: 628-632.
29. Turner AK, Nair S, Wain J, (2006) The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets. J Antimicrob Chemother 58: 733-740.
30. Ricci V, Tzakas P, Buckley A, Coldham NC, Piddock LJV, (2006) Ciprofloxacin-Resistant Salmonella enterica Serovar Typhimurium Strains Are Difficult to Select in the Absence of AcrB and TolC. Antimicrob Agents Chemother 50: 38-42.
31. Ricci V, Piddock LJV, (2009) Only for substrate antibiotics are a functional AcrAB-TolC efflux pump and RamA required to select multidrug-resistant Salmonella Typhimurium. J Antimicrob Chemother 64: 654-657.
32. Eaves DJ, Ricci V, Piddock LJV, (2004) Expression of acrB, acrF, acrD, marA, and soxS in Salmonella enterica Serovar Typhimurium: Role in Multiple Antibiotic Resistance. Antimicrob Agents Chemother 48: 1145-1150.
33. Zheng J, Cui SH, Meng JH, (2008) Effect of transcriptional activators RamA and SoxS on expression of multidrug efflux pumps AcrAB and AcrEF in fluoroquinolone-resistant Salmonella Typhimurium. J Antimicrob Chemother 63: 95-102.
34. Yu EW, McDermott G, Zgurskaya HI, Nikaido H, Koshland DE Jr, (2003) Structural Basis of Multiple Drug-Binding Capacity of the AcrB Multidrug Efflux Pump. Science 300: 976-980.
35. Seeger MA, Schiefner A, Eicher T, Verrey F, Diederichs K, et al. (2006) Structural Asymmetry of AcrB Trimer Suggests a Peristaltic Pump Mechanism. Science 313: 1295-1298.
36. Baucheron S, Tyler S, Boyd D, Mulvey MR, Chaslus-Dancla E, et al. (2004) AcrAB-TolC Directs Ef flux-Mediated Multidrug Resistance in Salmonella enterica SerovarTyphimurium DT104. Antimicrob Agents Chemother 48: 3729-3735.
37. Clinical and Laboratory Standards Institute (2008) Performance Standards for Antimicrobial Susceptibility Testing, 18th informational supplement M100-S18. CLSI, Wayne, PA.
38. Giraud E, Brisabois A, Martel JL, Chaslus-Dancla E, (1999) Comparative Studies of Mutations in Animal Isolates and Experimental In Vitro- and In Vivo-Selected Mutants of Salmonella spp. Suggest a Counter selection of Highly Fluoroquinolone-Resistant Strains in the Field. Antimicrob Agents Chemother 43: 2131-2137.
39. Datsenko KA, Wanner BL, (2000) One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products.Proc Natl Acad Sci USA 97: 6640-6645.
40. Mann BA, Slauch JM, (1997) Transduction of Low-Copy Number Plasmids by Bacteriophage P22. Genetics 146: 447-456.
41. Coldham NG, Webber M, Woodward MJ, Piddock LJV, (2010) A 96-well plate fluorescence assay for assessment of cellular permeability and active ef flux in Salmonella enterica serovar Typhimurium and Escherichia coli. J Antimicrob Chemother 65: 1655-1663.
42. Morita Y, Kataoka A, Shiota S, Mizushima T, Tsuchiya T, (2000) NorM of Vibrio parahaemolyticus is a Na+-Driven Multidrug Ef flux Pump. J Bacteriol 23: 6694-6697.
43. Horiyama T, Yamaguchi A, Nishino K, (2010) TolC dependency of multidrug ef flux systems in Salmonella enterica serovar Typhimurium. J Antimicrob Chemother 65: 1372-1376.
44. Yang S, Rahmati Clayton S, Zechiedrich EL, (2003) Relative contributions of the AcrAB, MdfA and NorE efflux pumps to quinolone resistance in Escherichia coli. J Antimicrob Chemother 51: 545-556.
45. Bailey AM, Paulsen IT, Piddock LJV, (2008) RamA Confers Multidrug Resistance in Salmonella enterica via Increased Expression of acrB, Which Is Inhabited by Chlorpromazine. Antimicrob Agents Chemother 52: 3604-3611.
46. Lee A, Mao W, Warren MS, Mistry A, Hoshino K, et al. (2000) Interplay between Ef flux Pumps May Provide Either Additive or Multiplicative Effects on Drug Resistance. J Bacteriol 182: 3142-3150.
47. Cristóbal RE, Vincent PA, Salomón PA, (2006) Multidrug resistance pump AcrAB-TolC is required for high-level, Tet(A)-mediated tetracycline resistance in Escherichia coli. J Antimicrob Chemother 58: 31-36.
48. Hawkey PM, (2003) Mechanisms of quinolone action and microbial response. J Antimicrob Chemother 51 (Suppl.): S29-35.
49. Hooper DC, (2001) Emerging Mechanisms of Fluoroquinolone Resistance. Emerg Infect Dis 7: 337-341.
50. Chinni SV, Raabe CA, Zakaria R, Randau G, Hoe CH, et al. (2010) Experimental identification and characterization of 97 novel npcRNA candidates in Salmonella enterica serovar Typhi. Nucleic Acids Res 38: 5893-5908.